Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)

About this update from Zealand Pharma A/s

Company announcement No. 33 / 2026Zealand Pharma - Transactions related to share buy-back program (week 29, 2026)Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the “Program”) for week 29 (July 13 - July 17, 2026). The Program is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 (the Market Abuse Regulation, “MAR”) and Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”). Reference is made to company announcement no. 15 / 2026 dated May 7, 2026, which sets out the full terms of the Program. Under the Program, Zealand Pharma may repurchase shares for a total consideration of up to DKK 1.3 billion. The maximum number of shares that may be acquired under the Program is 7,152,557, and the Program commenced on May 7, 2026, and will be completed no later than October 31, 2026. The Company has appointed Danske Bank as lead manager for the Program. Danske Bank will make its own trading decisions independently of, and without influence from, the Company.Transactions executed in week 29The following transactions have been executed on Nasdaq Copenhagen (XCSE) under the Program during week 29 (July 13, 2026 - July 17, 2026):DateNumber of sharesAverage purchase price (DKK)Transaction value (DKK)Accumulated as per latest announcement1,789,000 537,758,75013/07/2026 45,000 281.04 12,646,80014/06/2026 45,000 275.93 12,416,85015/07/2026 40,000 289.88 11,595,20016/07/2026 35,000 300.13 10,504,55017/07/2026 40,000 289.50 11,580,000Accumulated (W29)205,000 58,743,400Total accumulated under the Program1,994,000 596,502,150Treasury shares and share capital Following the transactions described above, Zealand Pharma holds a total of 2,864,482 treasury shares, corresponding to approximately 4% of the Company’s share capital. The total number of shares in Zealand Pharma is 71,578,758, each with a nominal value of DKK 1.Additional information Detailed information on each transaction executed under the Program is available in the appendix to this company announcement.About Zealand PharmaZealand Pharma A/S (Nasdaq: ZEAL) is a biotechn...

View stock analysis, news, and events for Zealand Pharma A/s